Some days, the inflammation and pain from rheumatoid arthritis makes it almost impossible for Tracy Braun to even sit up. “Sometimes I can’t even get up on my own,” she said. Braun is among a growing number of Americans who are finding it difficult to afford needed medicines, and a solution to their problem in Washington D.C. may continue to be elusive.
Continue Reading →
WASHINGTON – The president’s spokesman says Trump still favors a plan to negotiate Medicare prices, but he did not mention it after a recent meeting with pharmaceutical executives, and his plans to speed FDA approval of new drugs may be hampered by his restrictions on new regulations and cuts to the federal workforce. Continue Reading →
WASHINGTON — Sen. Richard Blumenthal wants to expand a program that allows U.S. companies to hire workers with specialized skills, but after allegations of abuses the senator also wants the program investigated. Continue Reading →
WASHINGTON – Rep. Rosa DeLauro is on a collision course with President Obama and some of Connecticut’s largest companies over a proposed trade deal with 12 countries on the Pacific Rim that span from Chile to Japan. DeLauro, D-3rd District, has become a leading opponent of the president’s plans for the Trans-Pacific Partnership, or TPP.
Continue Reading →
Pfizer Inc. remains an important, vibrant, active, taxpaying part of the Groton, southeastern Connecticut, and Connecticut landscape. Continue Reading →
WASHINGTON – Gov. Dannel Malloy is set to announce the Department of Economic and Community Development will provide Electric Boat $10 million in assistance to help the submarine maker purchase one of the buildings that housed Pfizer before the pharmaceutical company moved out of the state, a congressional source said. Continue Reading →
The Office of State Ethics said Monday that Diageo North America and Pfizer each have paid $5,000 penalties over their failure to report receptions they hosted at the 2012 Democratic National Convention as lobbying expenses. Continue Reading →
We must look at fixing possibly the biggest single barrier to Connecticut’s grabbing hold of its bright future … our badly broken, antiquated, unfair tax system. Continue Reading →
Washington – Corporations like Pfizer, United Technologies, Alexion and others spend millions on research each year, hoping to develop new products or processes that contribute to their bottom line. Continue Reading →
Charlotte, N.C. — The campaign pep talk for the Connecticut delegation to the Democratic National Convention came from the host, Gov. Dannel P. Malloy. But the drinks were on the worldwide beverage company, Diageo. “I’ve got to say the liquor here is not bad, either,” Malloy said Monday night. “We very much appreciate it, our friends who are supporting this event, very much appreciated. You have some of the best beers and best liquor available.” Continue Reading →